AI Startup Working To Target Cancer, Age-Related Disease Gets $37 Million Nod From Top VCs

The founder of an up and coming artificial intelligence (AI) company said targeting disease is a challenging if not herculean process, and it will take the science and skills of AI to conquer it. But it also takes a ton of money. That's why Insilico Medicine CEO Alex Zhavoronkov said his latest list of venture capitalists (VCs) are so crucial. They give an enormous amount of credibility to the new technology his company is developing . Finding the biological origin of a disease--the potential target for intervention--is the first step in discovering medicines to combat that disease.